Frédéric CARVALHO (EN)
UMR 1107 INSERM/UCA Neuro-Dol
Facultés de Médecine et Pharmacie
Place Henri Dunant
63001 Clermont-Ferrand
FRANCE
Dr. Frédéric CARVALHO
Research Scientist
Fundamental Pharmacology and Pain Clinic Team, Team FPPC – Microbial Metabolites and Chronic Pain Axis
frederic.carvalho@-Code to remove to avoid SPAM-uca.fr
Research Theme:
My project is focused on the study of the pathophysiology of chronic pain, mainly abdominal pain associated with IBS or IBD during periods of remission, in order to determine the mechanisms of chronicization of pain, with a particular focus on the influence of metabolites and interventional approaches in preclinical models. It lies at the interface between microbiology and neuroscience. This project is divided into two approaches: (1) Study the impact of the microbiota and its metabolites on chronic abdominal pain and “Well-being” by favoring the AhR/IL-22 pathway; (2) Evaluate the neuromodulatory power of bacteria with probiotic potential such as F. prausnitzii or P. distasonis.
Responsibilities:
Since 2013, I have directed or co-directed 4 M1, 8 M2 and 7 doctoral students, including 2 in progress.
- 10/12-12/2015: Co-supervision of L. BOUDIEU’s thesis, funded by a MENRT scholarship. Dr Boudieu is currently Clinical Research Associate at Clermont-Ferrand University Hospital.
- 10/14-06/2017: Co-supervision of thesis by A. LASHERMES, funded by a MENRT grant. Dr Lashermes is currently R&D Project Manager at Novobiome.
- 11/15-12/2018: Thesis director of Mr. DEFAYE, funded by a grant from the Auvergne-Rhône-Alpes region (“Thematic” funding Emerging”). Dr Defaye is currently carrying out a post-doctoral fellowship at the University of Calgary (Canada) with Professor Christophe ALTIER.
- 11/18-04/2022: Thesis director of Mr. MEYNIER, funded by a scholarship Region/FEDER (CPER “Nex-N-Mob” funding). Dr Meynier is currently carrying out a post-doctoral fellowship in the laboratory of Dr Emmanuel DEVAL, Institute of Molecular and Cellular Pharmacology (IPMC)/Université Côte d’Azur (Nice).
- 01/19-12/2022: Thesis director of S. GERVASON), with private funding (Greencell). Dr Gervason currently holds the position of R&D Project Manager at Biose Industrie. His thesis was rewarded with the Grand Prix for young researchers from the city of Clermont-Ferrand in 2023.
- Since 10/2021: Thesis director of V. DAUGEY, funded by a MENRT scholarship.
- Since 10/2023: Thesis director of N. VERDUIJN, funded by an FRM scholarship.
Recent article selections:
During my career, I have produced 40 articles (38 originals and 2 reviews) for a total of 4790 citations and an H-index of 23. Among these 40 publications, 16 are in PDC (6 as first author, 10 as last or co-last author and 11 as corresponding author). Publications are available on Web of Science and ORCID (#0000-0003-1592-2369). I was also an inventor in filing two patents. In addition, I have given 11 oral communications at international conferences (including 3 by invitation), as well as 15 communications displayed in the form of posters at international conferences.
- Meynier M, Daugey V, Mallaret G, Gervason S, Meleine M, Barbier J, Aissouni Y, Lolignier S, Bonnet M, Ardid D, De Vos WM, Van Hul M, Suenaert P, Brochot A, Cani PD, Carvalho FA. Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice. Gut Microbes. 2024 Jan-Dec;16(1):2298026. doi: 10.1080/19490976.2023.2298026.
- Gervason S, Meleine M, Lolignier S, Meynier M, Daugey V, Birer A, Aissouni Y, Berthon JY, Ardid D, Filaire E, Carvalho FA. Antihyperalgesic properties of gut microbiota: Parabacteroides distasonis as a new probiotic strategy to alleviate chronic abdominal pain. Bread. 2023 Sep 27. doi: 10.1097/j.pain.0000000000003075.
- Meynier M, Baudu E, Rolhion N, Defaye M, Straube M, Daugey V, Modoux M, Wawrzyniak I, Delbac F, Villeger R, Meleine M, Nogues E, Godfraind C, Barnich N, Ardid D, Poirier P, Sokol H, Chatel JM, Langella P, Livrelli V, Bonnet M, Carvalho FA*. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. Gut Microbes. 2022 Jan-Dec;14(1):2022997. doi: 10.1080/19490976.2021.2022997.
Additional Information:
- ORCID: 0000-0003-1592-2369
- LinkedIn: Frederic Carvalho
HAL Publications
Journal articles
2024
- ref_biblio
- Sandie Gervason, Mathieu Meleine, Stéphane Lolignier, Maëva Meynier, Valentine Daugey, et al.. Antihyperalgesic properties of gut microbiota: Parabacteroides distasonis as a new probiotic strategy to alleviate chronic abdominal pain. Pain, 2024, 165 (5), pp.e39-e54. ⟨10.1097/j.pain.0000000000003075⟩. ⟨hal-04316524⟩
- Accès au bibtex
-
- ref_biblio
- Maëva Meynier, Valentine Daugey, Geoffroy Mallaret, Sandie Gervason, Mathieu Meleine, et al.. Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice. Gut microbes, 2024, 16 (1), pp.2298026. ⟨10.1080/19490976.2023.2298026⟩. ⟨hal-04371864⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Fabien Rondepierre, Maëva Meynier, Johan Gagniere, Vincent Deneuvy, Anissa Deneuvy, et al.. Preclinical and clinical evidence of the association of colibactin-producing Escherichia coli with anxiety and depression in colon cancer. World Journal of Gastroenterology, 2024, 30 (21), pp.2817-2826. ⟨10.3748/wjg.v30.i21.2817⟩. ⟨hal-04601735⟩
- Accès au texte intégral et bibtex
-
2023
- ref_biblio
- Célia Chamignon, Geoffroy Mallaret, Julie Riviere, Marthe Vilotte, Sead Chadi, et al.. Beneficial Effects of Lactobacilli Species on Intestinal Homeostasis in Low-Grade Inflammation and Stress Rodent Models and Their Implication in the Modulation of the Adhesive Junctional Complex. Biomolecules, 2023, 13 (9), pp.1295. ⟨10.3390/biom13091295⟩. ⟨hal-04538013⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Sandie Gervason, Mathieu Meleine, Stéphane Lolignier, Maëva Meynier, Valentine Daugey, et al.. Antihyperalgesic properties of gut microbiota: Parabacteroides distasonis as a new probiotic strategy to alleviate chronic abdominal pain. Pain, 2023, ⟨10.1097/j.pain.0000000000003075⟩. ⟨hal-04687346⟩
- Accès au bibtex
-
- ref_biblio
- Flore Maillard, Maëva Meynier, Stanislas Mondot, Frederic Pepke, Chloé Galbert, et al.. From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders. Microorganisms, 2023, 11 (4), pp.906. ⟨10.3390/microorganisms11040906⟩. ⟨hal-04057783⟩
- Accès au texte intégral et bibtex
-
2022
- ref_biblio
- Geoffroy Mallaret, Amandine Lashermes, Mathieu Meleine, Ludivine Boudieu, Julie Barbier, et al.. Involvement of toll-like receptor 5 on mouse model of colonic hypersensitivity induced by neonatal maternal separation. World Journal of Gastroenterology, 2022, 28 (29), pp.3903-3916. ⟨10.3748/wjg.v28.i29.3903⟩. ⟨hal-03987265⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Maëva Meynier, Elodie Baudu, Nathalie Rolhion, Manon Defaye, Marjolène Straube, et al.. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. Gut microbes, 2022, 14 (1), pp.1-21. ⟨10.1080/19490976.2021.2022997⟩. ⟨hal-03555153⟩
- Accès au texte intégral et bibtex
-
2021
- ref_biblio
- S. Gervason, M. Defaye, D. Ardid, J.-Y. Berthon, C. Altier, et al.. Influence du microbiote sur la douleur. Douleur et Analgésie, 2021, 34 (2), pp.86-96. ⟨10.3166/dea-2021-0144⟩. ⟨hal-03516892⟩
- Accès au bibtex
-
- ref_biblio
- A.M. Hamieh, G. Mallaret, M. Meleine, A. Lashermes, S. Roumeau, et al.. Toll-like receptor 5 knock-out mice exhibit a specific low level of anxiety. Brain, Behavior, and Immunity, 2021, 93, pp.226-237. ⟨10.1016/j.bbi.2021.01.020⟩. ⟨hal-03516251⟩
- Accès au bibtex
-
2020
- ref_biblio
- Tanguy Chaumette, Lauriane Delay, Julie Barbier, Ludivine Boudieu, Youssef Aissouni, et al.. c-Jun/p38MAPK/ASIC3 pathways specifically activated by nerve growth factor through TrkA are crucial for mechanical allodynia development. Pain, 2020, pp.1. ⟨10.1097/j.pain.0000000000001808⟩. ⟨hal-02464551⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Manon Defaye, Céline Nourrisson, Elodie Baudu, Amandine Lashermes, Maeva Meynier, et al.. Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats. Scientific Reports, 2020, 10 (1), pp.9146. ⟨10.1038/s41598-020-66156-w⟩. ⟨inserm-02884871⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Manon Defaye, Sandie Gervason, Christophe Altier, Jean-Yves Berthon, Denis Ardid, et al.. Microbiota: a novel regulator of pain. Journal of Neural Transmission, 2020, 127 (4), pp.445-465. ⟨10.1007/s00702-019-02083-z⟩. ⟨hal-03036258⟩
- Accès au bibtex
-
2019
- ref_biblio
- Ludivine Boudieu, Sarah Mountadem, Amandine Lashermes, Mathieu Meleine, Lauriane Ulmann, et al.. Blocking α2δ-1 Subunit Reduces Bladder Hypersensitivity and Inflammation in a Cystitis Mouse Model by Decreasing NF-kB Pathway Activation. Frontiers in Pharmacology, 2019, 10, pp.133. ⟨10.3389/fphar.2019.00133⟩. ⟨hal-02324745⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Elodie Picard, Frédéric Antonio Carvalho, Francina Agosti, Emmanuel Bourinet, Denis Ardid, et al.. Inhibition of Cav3.2 calcium channels: A new target for colonic hypersensitivity associated with low‐grade inflammation. British Journal of Pharmacology, 2019, 176 (7), pp.950-963. ⟨10.1111/bph.14608⟩. ⟨hal-04317223⟩
- Accès au texte intégral et bibtex
-
2018
- ref_biblio
- Manon Defaye, Céline Nourrisson, Elodie Baudu, Ivan Warwzyniak, Virginie Bonnin, et al.. Efficient and reproducible experimental infections of rats with Blastocystis spp.. PLoS ONE, 2018, 13 (11), pp.1-15. ⟨10.1371/journal.pone.0207669⟩. ⟨hal-01931278⟩
- Accès au texte intégral et bibtex
-
2017
- ref_biblio
- Amandine Lashermes, Ludivine Boudieu, Julie Barbier, Benoit Sion, Agathe Gelot, et al.. Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period. Gut microbes, 2017, 9 (1), pp.26-37. ⟨10.1080/19490976.2017.1361091⟩. ⟨hal-04317240⟩
- Accès au bibtex
-
2016
- ref_biblio
- Mathieu Meleine, Ludivine Boudieu, Agathe Gelot, Emilie Muller, Amandine Lashermes, et al.. Comparative effects of alpha 2 delta-1 ligands in mouse models of colonic hypersensitivity. World Journal of Gastroenterology, 2016, 22 (31), pp.7111-7123. ⟨10.3748/wjg.v22.i31.7111⟩. ⟨hal-02636301⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- J. Scanzi, A. Accarie, E. Muller, Bruno Pereira, Y. Aissouni, et al.. Colonic overexpression of the T‐type calcium channel Cav 3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patients. Neurogastroenterology & Motility, 2016, 28 (11), pp.1632-1640. ⟨10.1111/nmo.12860⟩. ⟨hal-04317301⟩
- Accès au bibtex
-
2015
- ref_biblio
- S. Miquel, R. Martín, A. Lashermes, Marion Gillet, M. Meleine, et al.. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Scientific Reports, 2015, 6, pp.19399. ⟨10.1038/srep19399⟩. ⟨hal-01263911⟩
- Accès au texte intégral et bibtex
-
- ref_biblio
- Vishal Singh, Beng San Yeoh, Frédéric Antonio Carvalho, Andrew T Gewirtz, Matam Vijay-Kumar. Proneness of TLR5 deficient mice to develop colitis is microbiota dependent. Gut microbes, 2015, 6 (4), pp.279-283. ⟨10.1080/19490976.2015.1060390⟩. ⟨hal-03516833⟩
- Accès au texte intégral et bibtex
-
2014
- ref_biblio
- Benoit Chassaing, Omry Koren, Frédéric Antonio Carvalho, Ruth Ley, Andrew Gewirtz. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut, 2014, 63 (7), pp.1069-1080. ⟨10.1136/GUTJNL-2013-304909⟩. ⟨hal-03516826⟩
- Accès au bibtex
-
- ref_biblio
- Jason z. Oh, Rajesh Ravindran, Benoit Chassaing, Frédéric Antonio Carvalho, Mohan s. Maddur, et al.. TLR5-Mediated Sensing of Gut Microbiota Is Necessary for Antibody Responses to Seasonal Influenza Vaccination. Immunity, 2014, 41 (3), pp.478-492. ⟨10.1016/J.IMMUNI.2014.08.009⟩. ⟨hal-03516795⟩
- Accès au bibtex
-
- ref_biblio
- Jennifer Raisch, Adeline Sivignon, Benoit Chassaing, Pierre Lapaquette, Sylvie Miquel, et al.. In Memoriam, Arlette Darfeuille-Michaud, PhD. Gastroenterology, 2014, 147 (5), pp.943-944. ⟨10.1136/gutjnl-2014-308182⟩. ⟨hal-01951060⟩
- Accès au bibtex
-
2013
- ref_biblio
- Malin Johansson, Jenny Gustafsson, Jessica Holmén-Larsson, Karolina Jabbar, Lijun Xia, et al.. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut, 2013, 63 (2), pp.281-291. ⟨10.1136/GUTJNL-2012-303207⟩. ⟨hal-03516824⟩
- Accès au bibtex
-
2012
- ref_biblio
- Frederic A. Carvalho, Omry Koren, Julia K. Goodrich, Malin E. V. Johansson, Ilke Nalbantoglu, et al.. Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice. Cell Host and Microbe, 2012, 12 (2), pp.139 – 152. ⟨10.1016/j.chom.2012.07.004⟩. ⟨hal-02652647⟩
- Accès au bibtex
-
- ref_biblio
- F. A. Carvalho, I. Nalbantoglu, J. D. Aitken, R. Uchiyama, Y. Su, et al.. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunology, 2012, 5 (3), pp.288 – 298. ⟨10.1038/mi.2012.8⟩. ⟨hal-02648191⟩
- Accès au bibtex
-
- ref_biblio
- Frédéric Antonio Carvalho, Ilke Nalbantoglu, Sophie Ortega-Fernandez, Jesse Aitken, Yueju Su, et al.. Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut, 2012, 61 (3), pp.373-384. ⟨10.1136/GUT.2011.240556⟩. ⟨hal-03516776⟩
- Accès au bibtex
-
- ref_biblio
- Frédéric Antonio Carvalho, Jesse Aitken, Matam Vijay-Kumar, Andrew Gewirtz. Toll-Like Receptor–Gut Microbiota Interactions: Perturb at Your Own Risk!. Annual Review of Physiology, 2012, 74 (1), pp.177-198. ⟨10.1146/ANNUREV-PHYSIOL-020911-153330⟩. ⟨hal-03516778⟩
- Accès au bibtex
-
- ref_biblio
- Gayathri Srinivasan, Jesse Aitken, Benyue Zhang, Frédéric Antonio Carvalho, Benoit Chassaing, et al.. Lipocalin 2 Deficiency Dysregulates Iron Homeostasis and Exacerbates Endotoxin-Induced Sepsis. Journal of Immunology, 2012, 189 (4), pp.1911-1919. ⟨10.4049/JIMMUNOL.1200892⟩. ⟨hal-03516789⟩
- Accès au bibtex
-
2011
- ref_biblio
- Frédéric Antonio Carvalho, J Aitken, A Gewirtz, M Vijay-Kumar. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunology, 2011, 4 (1), pp.102-111. ⟨10.1038/MI.2010.57⟩. ⟨hal-03516764⟩
- Accès au bibtex
-
- ref_biblio
- Matam Vijay-Kumar, Jesse Aitken, Frédéric Antonio Carvalho, Thomas Ziegler, Andrew Gewirtz, et al.. Loss of function mutation in toll-like receptor-4 does not offer protection against obesity and insulin resistance induced by a diet high in trans fat in mice. Journal of Inflammation, 2011, 8 (1), pp.2. ⟨10.1186/1476-9255-8-2⟩. ⟨hal-03516761⟩
- Accès au bibtex
-
2010
- ref_biblio
- Matam Vijay-Kumar, Jesse Aitken, Frédéric Antonio Carvalho, Tyler Cullender, Simon Mwangi, et al.. Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5. Science, 2010, 328 (5975), pp.228-231. ⟨10.1126/SCIENCE.1179721⟩. ⟨hal-03516756⟩
- Accès au bibtex
-
- ref_biblio
- Matam Vijay-Kumar, Frédéric Antonio Carvalho, Jesse Aitken, Nimita Fifadara, Andrew Gewirtz. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. European Journal of Immunology, 2010, 40 (12), pp.3528-3534. ⟨10.1002/EJI.201040421⟩. ⟨hal-03516759⟩
- Accès au bibtex
-
2009
- ref_biblio
- Frédéric A Carvalho, Nicolas Barnich, Adeline Sivignon, Claude Darcha, Carlos H F Chan, et al.. Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. Journal of Experimental Medicine, 2009, 206 (10), pp.2179 – 2189. ⟨10.1084/jem.20090741⟩. ⟨hal-01931313⟩
- Accès au texte intégral et bibtex
-
2008
- ref_biblio
- Frédéric Antonio Carvalho, Nicolas Barnich, Pierre Sauvanet, Claude Darcha, Agathe Gelot, et al.. Crohnʼs disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflammatory Bowel Diseases, 2008, 14 (8), pp.1051-1060. ⟨10.1002/IBD.20423⟩. ⟨hal-03516742⟩
- Accès au texte intégral et bibtex
-
2007
- ref_biblio
- Nicolas Barnich, Frederic A. Carvalho, Anne-Lise Glasser, Claude Darcha, Peter Jantscheff, et al.. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. Journal of Clinical Investigation, 2007, 117 (6), pp.1566-1574. ⟨10.1172/JCI30504⟩. ⟨hal-02666899⟩
- Accès au bibtex
-
- ref_biblio
- Nathalie Rolhion, Frédéric Antonio Carvalho, Arlette Darfeuille-Michaud. OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn’s disease-associated Escherichia coli strain LF82. Molecular Microbiology, 2007, 63 (6), pp.1684-1700. ⟨10.1111/j.1365-2958.2007.05638.x⟩. ⟨hal-02662000⟩
- Accès au bibtex
-
2006
- ref_biblio
- J. Delmas, F. Robin, Frédéric Antonio Carvalho, C. Mongaret, R. Bonnet. Prediction of the Evolution of Ceftazidime Resistance in Extended-Spectrum β-Lactamase CTX-M-9. Antimicrobial Agents and Chemotherapy, 2006, 50 (2), pp.731-738. ⟨10.1128/AAC.50.2.731-738.2006⟩. ⟨hal-03516705⟩
- Accès au bibtex
-
Conference papers
2020
- ref_biblio
- Maeva Meynier, Elodie Baudu, Manon Defaye, Y Wawzyniak, Frederic Delbac, et al.. The IL-22 pathway as target to relieve visceral pain and animal well-being. ICTRHN, Jun 2020, Clermont-Ferrand, France. ⟨hal-02524613⟩
- Accès au bibtex
-
- ref_biblio
- Maeva Meynier, Elodie Baudu, Nicolas Barnich, Denis Ardid, Jean-Marc Chatel, et al.. Tryptophan derivatives effects via the AhR signaling pathway modulation on host disturbances after a Citrobacter rodentium infection. CELL SYMPOSIA, May 2020, PARIS, France. ⟨hal-03045712⟩
- Accès au bibtex
-
2019
- ref_biblio
- Frédéric Antonio Carvalho. Microbiote et sensibilité intestinale. Journée Probiotiques & microbiote intestinal, Feb 2019, lyon, France. ⟨hal-02363999⟩
- Accès au bibtex
-
Patents
2014
- ref_biblio
- Muriel Thomas, Philippe P. Langella, Luis Bermúdez-Humarán, Harry Sokol, Sylvie Miquel, et al.. Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain. France, Patent n° : 14306803.9. 2014. ⟨hal-04292693⟩
- Accès au bibtex
-
Poster communications
2021
- ref_biblio
- Delanne Améline, Jérémy Denizot, Ghislain Garrait, Khaled Fadhlaoui, Arthur Chevet, et al.. Development of a vector based on natural excipient in order to reduce the therapeutic doses of current treatments and their adverse effects in chronic inflammatory bowel diseases (IBD).. Young Researchers of Auvergne Rhône Alpes Region Congress, Jun 2021, Virtual conference, France. ⟨hal-03417146⟩
- Accès au bibtex
-
- ref_biblio
- Sandie Gervason, Edith Filaire, Mathieu Meleine, Denis Ardid, Jean-Yves Berthon, et al.. Strict anaerobic bacteria involvement in gut-brain axis: A novel regulator of visceral pain and well-being. Federation of Neurgastroenterology & Motility, Apr 2021, adélaïde, Australia. 32, 2020. ⟨hal-03038507⟩
- Accès au bibtex
-
2020
- ref_biblio
- Maeva Meynier, Elodie Baudu, Nicolas Barnich, Denis Ardid, J.M. Chatel, et al.. Effects of tryptophan derivatives via the AHR/Il22 signaling pathway modulation on host disturbances in post citrobacter rodentium infection model mimicking irritable bowel syndrome. UEGW 2020, Oct 2020, AMSTERDAM, Netherlands. ⟨hal-03046872⟩
- Accès au bibtex
-
2015
- ref_biblio
- F. Carvalho, A. Lashermes, S. Miquel, Rebeca Martin Rosique, A. Gelor, et al.. Impact of intestinal dysbiosis on mouse models of colonic hypersensitivity. NeuroGASTRO 2015, Jun 2015, Istanbul, Turkey. John Wiley and Sons, Neurogastroenterology and Motility, 27 (Suppl. S2), 2015, Neurogastroenterology and Motility. ⟨hal-01535295⟩
- Accès au bibtex
-